Category Archives: Healthcare

The Senior Officer of Avricore Health (Other OTC: AVCRF) is Selling Shares

Today, the Senior Officer of Avricore Health (AVCRF – Research Report), Rodger Mckendry Seccombe, sold shares of AVCRF for $23.75K. See today’s analyst top recommended stocks >> Based on Avricore Health’s latest earnings report for the quarter ending March 31,

Maxim Group Thinks Monopar Therapeutics Inc’s Stock is Going to Recover

Maxim Group analyst Jason McCarthy initiated coverage with a Buy rating on Monopar Therapeutics Inc (MNPR – Research Report) yesterday and set a price target of $11.00. The company’s shares closed last Thursday at $5.01, close to its 52-week low

Oppenheimer Thinks Vaccinex’s Stock is Going to Recover

Oppenheimer analyst Leland Gershell maintained a Buy rating on Vaccinex (VCNX – Research Report) today and set a price target of $7.00. The company’s shares closed last Thursday at $1.81, close to its 52-week low of $1.70. According to TipRanks.com,

Analysts Are Bullish on Top Healthcare Stocks: Marinus (MRNS), Moderna (MRNA)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Marinus (MRNS – Research Report) and Moderna (MRNA – Research Report) with bullish sentiments. Marinus (MRNS) Ladenburg Thalmann & Co. analyst Michael

The Chief Scientific Officer of Antibe Therapeutics (Other OTC: ATBPF) is Buying Shares

Yesterday, the Chief Scientific Officer of Antibe Therapeutics (ATBPF – Research Report), John Lawrence Wallace, bought shares of ATBPF for $26.46K. This recent transaction increases John Lawrence Wallace’s holding in the company by 11% to a total of $190.1K. In

A Director at DaVita (NYSE: DVA) is Buying Shares

Yesterday, a Director at DaVita (DVA – Research Report), John Nehra, bought shares of DVA for $461.2K. This recent transaction increases John Nehra’s holding in the company by 10.28% to a total of $5.07 million. See today’s analyst top recommended